Belite Bio (BLTE) Current Leases (2022 - 2025)

Belite Bio (BLTE) posted quarterly Current Leases of $241000.0 for Q4 2025, down 12.68% year-over-year from $276000.0 in Q4 2024, and down 9.06% quarter-over-quarter from $265000.0 in Q3 2025.

Belite Bio (BLTE) Current Leases (2022 - 2025) Analysis & Trends

Belite Bio's Current Leases history runs 4 years deep, the most recent figure standing at $241000.0 for Q4 2025.

  • In Q4 2025, Current Leases fell 12.68% year-over-year to $241000.0; the TTM figure through Dec 2025 stood at $241000.0 (down 12.68% YoY), while the FY2025 annual figure was $241000.0, down 12.68% from the prior year.
  • Current Leases for Q4 2025 stood at $241000.0, down from $265000.0 in the prior quarter.
  • The five-year high for Current Leases was $308000.0 in Q4 2023, with the low at $198000.0 in Q4 2022.
  • The 4-year median for Current Leases is $265000.0 (2025), against an average of $257600.0.
  • The sharpest annual moves came in 2023 and 2025: Current Leases jumped 55.56% in 2023, then fell 12.68% in 2025.
  • Belite Bio's Current Leases stood at $198000.0 in 2022, then surged by 55.56% to $308000.0 in 2023, then fell by 10.39% to $276000.0 in 2024, then dropped by 12.68% to $241000.0 in 2025.
  • Business Quant data shows BLTE's Current Leases at $241000.0 in Q4 2025, $265000.0 in Q3 2025, and $276000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 11.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 16.75 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 21.95 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 2.24 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 45.93 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 6.27 Mn
10 Belite Bio 6.40 Bn 6.40 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 241,000.00
Sep 30, 2025 265,000.00
Dec 31, 2024 276,000.00
Dec 31, 2023 308,000.00
Dec 31, 2022 198,000.00